Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (421-430 of 511) with videos related to

Pageof 52
Sort By:
BMJ Open|June 13, 2024
Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiativeJohn W Pickering, Gerard Devlin, Richard Body, et al.
Ebiomedicine|August 27, 2020
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastomaSally L George, Federica Lorenzi, David King, et al.
Cancer Discovery|February 13, 2014
An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressorNirupa Murugaesu, Marjan Iravani, Antoinette van Weverwijk, et al.
Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.
Cancer|July 9, 2004
Reproductive factors and risk of breast carcinoma in a study of white and African-American womenGiske Ursin, Leslie Bernstein, Yaping Wang, et al.
The British Journal of Dermatology|March 4, 2026
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alphaKirsty Hodgson, Joseph Inns, Gary Reynolds, et al.
Nature Cell Biology|January 11, 2022
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatinDragomir B Krastev, Shudong Li, Yilun Sun, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Cancer Research|October 18, 2017
ATR Is a Therapeutic Target in Synovial SarcomaSamuel E Jones, Emmy D G Fleuren, Jessica Frankum, et al.
Research Square|March 11, 2024
Rare Variants Analyses Suggest Novel Cleft Genes in the African PopulationAzeez Alade, Peter Mossey, Waheed Awotoye, et al.
Pageof 52

Showing results (421-430 of 511) with videos related to

Sort By:
Pageof 52
BMJ Open|June 13, 2024
Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiativeJohn W Pickering, Gerard Devlin, Richard Body, et al.
Ebiomedicine|August 27, 2020
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastomaSally L George, Federica Lorenzi, David King, et al.
Cancer Discovery|February 13, 2014
An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressorNirupa Murugaesu, Marjan Iravani, Antoinette van Weverwijk, et al.
Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.
Cancer|July 9, 2004
Reproductive factors and risk of breast carcinoma in a study of white and African-American womenGiske Ursin, Leslie Bernstein, Yaping Wang, et al.
The British Journal of Dermatology|March 4, 2026
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alphaKirsty Hodgson, Joseph Inns, Gary Reynolds, et al.
Nature Cell Biology|January 11, 2022
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatinDragomir B Krastev, Shudong Li, Yilun Sun, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Cancer Research|October 18, 2017
ATR Is a Therapeutic Target in Synovial SarcomaSamuel E Jones, Emmy D G Fleuren, Jessica Frankum, et al.
Research Square|March 11, 2024
Rare Variants Analyses Suggest Novel Cleft Genes in the African PopulationAzeez Alade, Peter Mossey, Waheed Awotoye, et al.
Pageof 52